Purple Innovation Extends Maturity of Debt and Reschedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call Accessibility StatementSkip Navigation LEHI, Utah, March 24, 2026 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple"), a comfort innovation company whose mattresses promise to give you "less pain, better sleep," today announced that it has extended the maturity of its debt from December 31, 2026 to April 30, 2027. In addition, Purple is rescheduling the release of i ...

Purple Innovation to Report Fourth Quarter and Full Year 2025 Results on March 25, 2026 Accessibility StatementSkip Navigation LEHI, Utah, March 24, 2026 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple"), a comfort innovation company whose mattresses promise to give you "less pain, better sleep," will report fourth quarter and full year 2025 financial results on Wednesday, March 25, 2026 at approximately 8:00 a.m. ET. The Company will hold a conference call that day at 8:30 a.m. ET to review ...

Core Insights - Purple Innovation, Inc. has announced positive results from independent studies validating the effectiveness of its GelFlex Grid® mattresses in reducing pain and improving sleep quality [1][2][3] Group 1: Study Findings - Two independent studies conducted by SleepScore Labs involved over 3,300 nights of sleep data, confirming that Purple mattresses significantly reduce pain-related sleep disruptions [2][3] - Participants experienced a 68% reduction in pain with the Purple Essentials mattress and a 63% reduction with the Purple Restore mattress [3] - The studies showed that users of the Essentials mattress fell asleep 8% faster and woke up 6% less often, while Restore users spent an additional 3.5 hours in deep sleep per month and reported a 204% increase in their ability to sleep through the night without tossing and turning [6] Group 2: Impact on Well-Being - Improvements in sleep quality and pain reduction are linked to enhanced cognitive performance, vitality, and overall wellness [3][4] - Participants reported feeling well-rested increased by 96% for Essentials users and 174% for Restore users, with self-reported sleep quality improving by 90% and 170% respectively [6] Group 3: Technology and Innovation - The GelFlex Grid technology, originally developed for medical applications, provides a unique combination of pressure relief, alignment, and temperature balance, contributing to better sleep and reduced pain [5][8] - The findings validate Purple's approach to sleep innovation and highlight the importance of well-designed sleep surfaces in enhancing nighttime recovery [6][10]

Core Insights - Purple's shares surged 17.1% following the release of its third-quarter 2025 earnings report, indicating positive investor sentiment due to signs of improvement in the company's performance [1][2] - The financial update revealed a slight increase in revenue and enhanced profitability metrics, attributed to strategic initiatives and product innovations [2] - The stock closed at $0.82, reflecting a 17.3% increase from the previous close, suggesting a strong market reaction to the earnings report [2] Financial Performance - Purple reported a slight revenue increase and improved profitability metrics, which were key factors in the positive market response [2] - The company is currently trading at $0.83 per share, which is 33.6% below its 52-week high of $1.25 reached in August 2025 [6] - Year-to-date, Purple's shares have increased by 10.8%, indicating a recovery trend despite being significantly below past highs [6] Market Dynamics - The stock has exhibited extreme volatility, with 62 moves greater than 5% over the past year, highlighting the significant impact of recent news on market perception [4] - The previous notable stock movement occurred 14 days prior, when shares rose 4.8% due to a cooler-than-expected inflation report, which influenced investor sentiment across interest-sensitive sectors [5]

Core Insights - Purple Innovation, Inc. is recognized for its innovative comfort technology in mattresses and bedding products, but it faces challenges in capital efficiency [1] - The company's Return on Invested Capital (ROIC) is -19.51%, while its Weighted Average Cost of Capital (WACC) is 9.87%, leading to a negative ROIC to WACC ratio of -1.98, indicating poor capital utilization [2][6] - In contrast, Vroom, Inc. demonstrates efficient capital utilization with a ROIC of 14.05% and a WACC of 8.39%, resulting in a positive ROIC to WACC ratio of 1.67 [4][6] - Other industry peers, such as The RealReal, Inc. and CarParts.com, Inc., also exhibit negative ROIC to WACC ratios of -2.53 and -8.61, respectively, highlighting a common challenge of capital inefficiency in the sector [5][6] Comparative Analysis - The Lovesac Company has a ROIC of 7.16% and a WACC of 9.71%, resulting in a ROIC to WACC ratio of 0.74, indicating it is closer to breaking even compared to Purple Innovation [3] - The negative ROIC to WACC ratios of Purple Innovation and its peers emphasize the need for strategic improvements in capital management across the industry [5][6]

Group 1 - The article does not provide any specific content or key points related to a company or industry [1]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $118.8 million, a slight increase from $118.6 million in the previous year, marking an important inflection point after consecutive declines [4][16] - Adjusted EBITDA for the quarter was a gain of $200,000, an improvement from a loss of $6.4 million in the prior year, driven by gross margin expansion and disciplined cost management [19] - Gross margin improved to approximately 42.8% from 29.7% in the prior year, reflecting direct material cost savings and improved operational efficiencies [17][19] Business Line Data and Key Metrics Changes - Direct-to-consumer net revenue was $67.2 million, down 5.1% year-over-year, with showroom revenue increasing by 6.5% to $22 million despite fewer stores [16][17] - Wholesale revenue grew by 7.9% to $51.5 million, driven by the Rejuvenate 2.0 launch and expansion with Mattress Firm [17][20] - E-commerce revenue decreased by 9.8% but showed signs of improvement following a website refresh [10][17] Market Data and Key Metrics Changes - The company is on track to reach 12,000 slots in Mattress Firm by March 2026, representing approximately $20 million in incremental revenue this year and an anticipated $70 million next year [11][20] - The overall market appears to be stabilizing, with expectations of flattish results in the category, indicating a potential bottoming out [22][24] Company Strategy and Development Direction - The company is focused on innovation, marketing, and strategic partnerships, with a strong emphasis on the Rejuvenate 2.0 product line and expanding retail partnerships [7][12] - The restructuring program initiated in August 2024 has led to reduced fixed costs and improved operational efficiency, with expected annual savings of $25-$30 million [6][20] - The company aims to maintain gross margins above 40% while continuing to invest in showroom expansion and innovation [14][20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning for future growth, despite acknowledging challenges in the broader market [7][24] - The company reiterated its full-year guidance, expecting revenue between $465 million and $485 million and adjusted EBITDA between break-even and $10 million positive [14][20] Other Important Information - The company is engaged in ongoing discussions regarding strategic alternatives, including potential mergers or sales, but will not comment further during the call [15] - Cash and cash equivalents at the end of September were $32.4 million, up from $29 million at the end of 2024, indicating improved liquidity [19][20] Q&A Session Summary Question: What are the encouraging signs in the industry overall? - Management noted that while the market showed signs of improvement around Labor Day, the latter part of September was mixed and soft, but they are encouraged by the performance in October [22][24] Question: Can you discuss margin opportunities for 2026? - Management indicated that gross margins are expected to remain around 40%, with efficiencies from restructuring efforts contributing positively [25][31] Question: How much of the improvement in wholesale was driven by Mattress Firm slots? - The Mattress Firm launch initially hurt productivity due to increased slots, but overall productivity has held steady, which is encouraging [36] Question: What is the long-term e-commerce opportunity for Purple? - Management remains bullish on e-commerce, noting improvements following a website refresh and ongoing efforts to enhance the channel's performance [33] Question: How is showroom profitability trending? - 76% of showrooms were profitable in Q3, up from 56% the previous year, indicating positive progress in this channel [34]

Financial Performance - Third quarter 2025 net revenue was $118.8 million, a slight increase from $118.6 million in the same quarter of 2024, driven by Rejuvenate 2.0 shipments and Mattress Firm partnership expansion [4]. - Gross profit for the third quarter increased to $50.9 million, representing 42.8% of net revenue, compared to $35.2 million or 29.7% in the prior year period [5]. - Net loss for the third quarter was $11.7 million, significantly improved from $39.2 million in the prior year [7]. - Adjusted EBITDA for the third quarter was $0.2 million, an improvement from $(6.4) million last year, attributed to strong gross margin performance and disciplined cost management [7]. - Revenues for the three months ended September 30, 2025, were $118.766 million, a slight increase from $118.598 million in the same period of 2024 [22]. - Gross profit for the three months ended September 30, 2025, was $50.851 million, compared to $35.193 million in 2024, reflecting a significant improvement [22]. - The net loss for the three months ended September 30, 2025, was $11.748 million, an improvement from a net loss of $39.310 million in the same period of 2024 [22]. - Adjusted net loss for the three months ended September 30, 2025, was $8,632,000, resulting in an adjusted net loss per diluted share of $0.08, compared to an adjusted net loss of $13,828,000 and $0.13 per diluted share in 2024 [34]. - For the nine months ended September 30, 2025, the net loss attributable to Purple Innovation, Inc. was $48,285,000, compared to $89,587,000 for the same period in 2024 [36]. - Adjusted net loss for the nine months ended September 30, 2025, was $32,269,000, with an adjusted net loss per diluted share of $0.30, compared to an adjusted net loss of $48,035,000 and $0.45 per diluted share in 2024 [36]. Cost Management - Operating expenses decreased by 23.2% to $63.0 million from $82.0 million in the prior year quarter, primarily due to reduced restructuring and impairment charges [6]. - Total operating expenses decreased to $62.977 million for the three months ended September 30, 2025, from $82.006 million in 2024, indicating a reduction of approximately 23.3% [22]. - Total cost of revenues for the three months ended September 30, 2025, was $67.915 million, down from $83.405 million in 2024, reflecting a decrease of approximately 18.5% [30]. - Restructuring related charges for the three months ended September 30, 2025, amounted to $5,290,000, while for the nine months, it was $12,382,000 [32]. Cash and Inventory - Cash and cash equivalents as of September 30, 2025, were $32.4 million, up from $29.0 million as of December 31, 2024 [8]. - Cash and cash equivalents at the end of the period were $32.358 million, an increase from $23.399 million at the end of September 30, 2024 [24]. - Net inventories as of September 30, 2025, totaled $65.8 million, a 9.8% increase compared to September 30, 2024 [8]. - Net cash used in operating activities for the nine months ended September 30, 2025, was $28.030 million, compared to $24.611 million in 2024 [24]. Guidance and Future Outlook - The company maintains its 2025 guidance, projecting full-year revenue of $465 to $485 million and adjusted EBITDA of breakeven to $10 million [9]. - The success of Rejuvenate 2.0 and the Mattress Firm partnership is expected to support continued growth in the premium segment [3]. - The restructuring program has been completed, leading to improved manufacturing efficiencies and direct material cost savings [5]. Tax and Other Financial Metrics - The effective tax rate for the three and nine months ended September 30, 2025, was estimated at 25.9% [35]. - Revenue reduction due to SGI Contract for the three months ended September 30, 2025, was $941,000, and for the nine months, it was $1,568,000 [32]. - The change in fair value of warrant liabilities for the three months ended September 30, 2025, was $(6,892,000), and for the nine months, it was $(11,319,000) [32]. - The company reported a gain on insurance proceeds of $(7,301,000) for the three months ended September 30, 2024, and $(11,601,000) for the nine months [32]. - Board special committee fees for the three months ended September 30, 2025, were $698,000, and for the nine months, they totaled $1,958,000 [32].

Financial Performance - Total revenues for Q3 2025 were $118.766 million, a slight increase from $118.598 million in Q3 2024, while year-to-date revenues decreased to $328.037 million from $358.902 million[13]. - Gross profit for Q3 2025 was $50.851 million, compared to $35.193 million in Q3 2024, indicating a significant improvement in profitability[13]. - Operating loss for Q3 2025 was $12.126 million, an improvement from a loss of $46.813 million in Q3 2024[13]. - Net loss attributable to Purple Innovation, Inc. for Q3 2025 was $11.720 million, compared to a net loss of $39.228 million in Q3 2024[13]. - For the nine months ended September 30, 2025, the company reported a net loss of $48.3 million, an improvement from a net loss of $89.6 million in the same period of 2024, representing a 46% reduction in losses[18]. - The Company reported a pretax loss of $48.1 million for the nine months ended September 30, 2025, compared to a pretax loss of $89.4 million for the same period in 2024[146]. Cash and Liquidity - Cash and cash equivalents increased to $32.358 million as of September 30, 2025, up from $29.011 million at the end of 2024[11]. - The company reported a net increase in cash and cash equivalents of $3.3 million for the nine months ended September 30, 2025, compared to a decrease of $3.5 million in the same period of 2024[18]. - Cash flows from operating activities resulted in a net cash used of $28.0 million for the nine months ended September 30, 2025, compared to $24.6 million for the same period in 2024[18]. - The company expects to have sufficient liquidity to fund its operations for at least one year from the date of the report issuance[30]. Assets and Liabilities - Total current assets rose to $136.406 million as of September 30, 2025, compared to $126.368 million at the end of 2024[11]. - Total liabilities increased to $329.028 million as of September 30, 2025, from $287.636 million at the end of 2024[11]. - The accumulated deficit grew to $(622.068) million as of September 30, 2025, compared to $(573.866) million at the end of 2024[11]. Operating Expenses and Cost Management - Operating expenses for Q3 2025 were $62.977 million, down from $82.006 million in Q3 2024, reflecting cost management efforts[13]. - The company has taken additional cost-saving initiatives to maintain liquidity and support its operations and strategies during the first nine months of 2025[29]. - The company recognized $5.3 million in costs related to the Restructuring Plan during the three months ended September 30, 2025[189]. Debt and Financing - Total debt as of September 30, 2025, was $102,889,000, an increase of 85.5% from $55,394,000 as of December 31, 2024[70]. - The Company entered into an amended credit agreement on January 23, 2024, which included a term loan of $61.0 million and provided net proceeds of approximately $27.0 million[73]. - The 2025 Amendment increased the initial principal amount of the Related Party Loan by $19.0 million, bringing the total to $80.0 million[79]. - The Second 2025 Amendment increased the initial principal amount of the senior secured term loan facility by $20.0 million, raising the total to $100.0 million[87]. Inventory and Revenue Streams - DTC revenue for the three months ended September 30, 2025, was $45.275 million, a decrease from $50.211 million in the same period of 2024, while wholesale revenue was $51.541 million, up from $47.775 million[58]. - The Company reported inventory levels of $65.770 million as of September 30, 2025, an increase from $56.863 million at the end of 2024[60]. - The expansion with Mattress Firm is progressing well, with Purple products represented in approximately 9,200 slots, aiming for a minimum of 12,000 slots by 2026, expected to generate $20 million in incremental revenue this year and $70 million next year[187]. Legal and Regulatory Matters - The Company is involved in various legal proceedings, including a class action lawsuit regarding employment-related claims, which has resulted in a settlement agreement expected to be approved by the California Superior Court[124]. - The Company has engaged in related party transactions, particularly with Coliseum Capital Management, LLC, which has significant control over certain securities[128]. Stock and Warrants - The Company issued 20.0 million warrants with a fair value of $19.6 million upon the initial credit agreement[74]. - The Company issued a total of 40,787 thousand warrants as of September 30, 2025, compared to 20,000 thousand warrants at December 31, 2024[141]. - The exercise price for all warrant tranches is $1.50, with expiration dates ranging from January 23, 2034, to March 12, 2035[141]. Tax Matters - The effective tax rate for the nine months ended September 30, 2025, was (0.31%), compared to (0.20%) for the same period in 2024, primarily due to a full valuation allowance against deferred tax assets[146]. - The Company had unrecognized tax benefits of $1.1 million as of September 30, 2025[149].

Core Points - Purple Innovation, Inc. is set to report its third quarter 2025 financial results on November 4, 2025, at approximately 4:05 p.m. ET [1] - A conference call will be held on the same day at 4:30 p.m. ET to discuss the financial results [1]